Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 28Sarcoma 15Lymphoid 2Other hematologic neoplasm 1Head & Neck 1

Conditions

Oligodendroglioma 1Medulloblastoma 1Lymphoma 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

regorafenib 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Nivolumab 2Filgrastim 2Cisplatin 2Bevacizumab 2vocimagene amiretrorepvec 1tovorafenib 1pembrolizumab 1entinostat 1aflibercept 1Thiotepa 1Thalidomide 1Temozolomide 1Tamoxifen 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1NEO212 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Irinotecan 1Ipilimumab 1Immunotherapy 1IFL protocol 1Flucytosine 1Fentanyl 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Astrocytoma × Carmustine × Head & Neck × Clear all
NCT00007982 2013-02-04

Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer

National Cancer Institute (NCI)

Phase 2 Completed
30 enrolled
CNSHead & NeckLymphoid

Astrocytoma, Brain Neoplasms, Head and Neck Neoplasms, Lymphoma, Medulloblastoma, Oligodendroglioma, Central Nervous System Neoplasms, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡